Strahlentherapie und Onkologie
短名 | Strahlenther Onkol |
Journal Impact | 2.66 |
国际分区 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING(Q2) |
期刊索引 | SCI Q2中科院 3 区 |
ISSN | 0179-7158, 1439-099X |
h-index | 78 |
国内分区 | 医学(3区)医学核医学(3区)医学肿瘤学(4区) |
STRAHLENTHERAPIE UND ONKOLOGIE 每月出版,是一本涵盖肿瘤学各个方面的科学期刊,重点是放射肿瘤学、放射生物学和放射物理学。这些文章不仅对放射肿瘤学家感兴趣,而且对所有对肿瘤学感兴趣的医生、放射生物学家和放射物理学家都感兴趣。该期刊发表经过同行评审的原创文章、评论文章和案例研究。它包括科学简短的交流以及带有注释文章的文献综述,这些文章向读者介绍了相关学科的新发展,从而可以对放射肿瘤学研究的最新成果进行全面概述。 STRAHLENTHERAPIE UND ONKOLOGIE 成立于 1912 年,是世界上最古老的肿瘤学杂志。今天,文稿以英语和德语出版。所有文章都有英文摘要和图例。该杂志是几个科学放射肿瘤学会的官方出版物,并出版这些学会的相关通讯。
期刊主页投稿网址涉及主题 | 医学内科学外科放射科放射治疗生物遗传学病理癌症核医学物理肿瘤科化学 |
出版信息 | 出版商: Urban und Vogel,出版周期: Monthly,期刊类型: journal |
基本数据 | 创刊年份: 1986,原创研究文献占比: 89.81%,自引率:22.20%, Gold OA占比: 58.23% |
平均审稿周期 | 网友分享经验:一般,3-8周 |
平均录用比例 | 网友分享经验:较难 |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Is intensive training with a time interval between instruction and planning CT necessary for deep inspiration breath-hold radiotherapy in breast cancer?
2024-9-13
Magnetic resonance imaging-based radiomics for predicting infiltration levels of CD68+ tumor-associated macrophages in glioblastomas
2024-9-13
Preclinical monitoring of radiation-induced brain injury via GluCEST MRI and resting-state fMRI at 7 T: an exploratory study on MRI-guided OAR avoidance
2024-9-11
Allies not enemies—creating a more empathetic and uplifting patient experience through technology and art
2024-9-11
Integrated MRI radiomics, tumor microenvironment, and clinical risk factors for improving survival prediction in patients with glioblastomas
2024-9-9
Change in the serum selenium level of patients with non-metastatic and metastatic non-small cell lung cancer (NSCLC) during radiotherapy as a predictive factor for survival
2024-9-6
Verbesserung der Ernährungssituation von Patienten mit fortgeschrittenem kleinzelligem Lungenkarzinom (NSCLC) durch Off-label-Medikation
2024-9-5
Pembrolizumab plus Radiochemotherapie bei lokal fortgeschrittenem Zervixkarzinom – die prospektive, randomisierte KEYNOTE-A18-Phase-3-Studie
2024-9-4
Management of patients with reduced dihydropyrimidine dehydrogenase activity receiving combined 5-fluoruracil-/capecitabine-based chemoradiotherapy
2024-9-4
Adjuvant (chemo)radiotherapy for patients with head and neck cancer: can comorbidity risk scores predict outcome?
2024-9-2
Pilot study to assess the early cardiac safety of carbon ion radiotherapy for intra- and para-cardiac tumours
2024-8-30
Artificial intelligence for response prediction and personalisation in radiation oncology
2024-8-30
Robust IMPT and follow-up toxicity in skull base chordoma and chondrosarcoma—a single-institution clinical experience
2024-8-29
The risk of second malignancies following prostate cancer radiotherapy in the era of conformal radiotherapy: a statement of the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO)
2024-8-28
Multi-institutional analysis of extracranial oligometastatic colorectal cancer patients treated with stereotactic body radiation therapy: TROD 02-008 study
2024-8-19
Validation of the implementation of phased-array heating systems in Plan2Heat
2024-8-14
Artificial intelligence for treatment delivery: image-guided radiotherapy
2024-8-13
Conversion chemoradiotherapy combined with nab-paclitaxel plus cisplatin in patients with locally advanced borderline-resectable or unresectable esophageal squamous cell carcinoma: a phase i/ii prospective cohort study
2024-8-12
Whole brain radiation therapy for patients with brain metastases: survival outcomes and prognostic factors in a contemporary institutional series
2024-8-12
Implementation of PET/CT in radiation oncology—a patterns-of-care analysis of the German Society of Nuclear Medicine and the German Society of Radiation Oncology
2024-8-9
Standardtherapie mit oder ohne SBRT bei Patienten mit oligoprogredientem Brustkrebs oder NSCLC („CURB oligoprogression“): eine offene, randomisierte, kontrollierte Phase-2-Studie
2024-8-9
Outcome of intraoperative brachytherapy as a salvage treatment for locally recurrent rectal cancer
2024-8-8
Deep learning for autosegmentation for radiotherapy treatment planning: State-of-the-art and novel perspectives
2024-8-6
Principles of artificial intelligence in radiooncology
2024-8-6
Long-term analysis of hematological parameters as predictors of recurrence patterns and treatment outcomes in cervical cancer patients undergoing definitive chemoradiotherapy
2024-8-5
Correction to: Low-dose radiotherapy for greater trochanteric pain syndrome—a single-centre analysis
2024-8-2
Sarcopenia in glioblastoma: the imaging we need and what it tells us
2024-8-2
Sarcopenia in glioblastoma: pick up the probe and ditch the tomography
2024-8-2
Protocol-based CT-guided brachytherapy for patients with prostate cancer and previous rectal extirpation—a curative approach
2024-8-2
Stellenwert einer „targeted therapy“ beim EGFR-mutierten Lungenkarzinom nach erfolgter Radiochemotherapie
2024-8-2
Induktionstherapie mit Nivolumab und Chemotherapie bei HPV-positiven Oropharynxkarzinomen
2024-7-29
Proton therapy reduces the effective dose to immune cells in breast cancer patients
2024-7-25
Postoperative radiotherapy for pT1–2N0 oral tongue carcinoma: time to reconsider?
2024-7-23
Ein 34-Genexpressionsbiomarker zur Prädiktion des onkologischen Outcomes und des Therapieansprechens nach Bestrahlung bei Meningeomen
2024-7-20
Systemische Therapie mit oder ohne lokal ablative Therapie beim oligometastasierten Plattenepithelkarzinom des Ösophagus
2024-7-19
Bestrahlung des Herzens zur Verbesserung der linksventrikulären Funktion
2024-7-17
Dose prescription for stereotactic body radiotherapy: general and organ-specific consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery
2024-7-12
Rare case of myelodysplastic syndrome with excess blasts 2 developing after adjuvant chemoradiotherapy for triple-negative breast cancer in a patient with Bloom syndrome
2024-7-12
Effect of different optimization parameters in single isocenter multiple brain metastases radiosurgery
2024-7-8
Initial needle tracking with the first standalone combined infrared camera – CT system for brachytherapy—analysis of tracking accuracy and uncertainties
2024-7-5
Tolerance of radiotherapy with concomitant glofitamab in diffuse large B cell lymphoma: a case report
2024-7-2
Friedrich Dessauer (1881–1963): the forgotten medical physicist, politician, and philosopher
2024-6-27
Impact of dose volume parameters and clinical characteristics on radiation-induced acute oral mucositis for head and neck cancer patients treated with carbon-ion radiotherapy dose volume outcome analysis
2024-6-26
Timing of development of osteoradionecrosis post head and neck radiotherapy: does a safe time interval exist for dental extraction?
2024-6-25
The effect of incidental dose to pelvic nodes in bladder-only irradiation in the era of IMRT: a dosimetric study
2024-6-18
Regression of all untreated lesions in multifocal low-grade meningioma following fractionated stereotactic radiotherapy—abscopal effect or spontaneous regression?
2024-6-13
Clinical and MRI risk factors predicting post-irradiation carotid blowout syndrome in patients with nasopharyngeal cancer
2024-6-13
Pulmonary artery intimal sarcoma: Case report of a patient managed with multimodality treatment and a comprehensive literature review
2024-6-12
Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost
2024-6-3
Cost-effectiveness analysis of bevacizumab for cerebral radiation necrosis treatment based on real-world utility value in China
2024-6-3
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远